The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration
Open accessAbstract
The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed different phenotypes that are inherently associated with disease conditions. A common feature of some of these activated phenotypes is the upregulation of galectin-3. Representative examples of these phenotypes include disease-associated microglia (DAM) and white-associated microglia (WAM), whose role(s) in neuroprotection/neurotoxicity is a matter of high interest in the microglia community. In this review, we summarise the main findings that demonstrate the ability of galectin-3 to interact with key pattern recognition receptors, including, among others, TLR4 and TREM2 and the importance of galectin-3 in the regulation of microglia activation. Finally, we discuss increasing evidence supporting the involvement of this lectin in the main neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, multiple sclerosis, traumatic brain injury, and stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Illustration from Burguillos et al. 2015 [31]: Gal-3 acts as a ligand to TLR4. Left panel: Colocalisation of Gal-3 and TLR4 in BV2 cells after 1 h exposure with sGal-3 protein. Right panel: Microscale thermophoresis was used to analyse the direct binding of TLR4 to Gal-3, Gal-3 CRD, Gal-3 R186S, and Gal-3 in the presence of inhibitory lactose (40 mM). Whereas the concentration of fluorescently labelled TLR4 was kept constant, the non-labelled proteins were titrated (x axis), and the minimal and maximal Fnorm values of the unbound and bound state of TLR4, respectively, were used to calculate the percent of TLR4 bound to Gal-3 (y axis).](https://figures.cochat.ai/paper-figures/400d6e178fb14461a20873663e99f0c7/galectin-3-a-rising-star-in-modulating-microglia-activation-under-conditions-of-figure-1.jpg)
![Fig. 2 Illustration from Boza-Serrano et al. 2019 [13]: Gal-3 interacts with TREM2. Left panel: Gal-3 and TREM2 in plaque-associated microglia in the brain of 5xFAD mice reveal colocalisation of Gal-3 and TREM2. Right panel: Gal-3 and TREM2 interaction in 5xFAD mouse brain using Stochastic Optical Reconstruction Microscopy (STORM). All images were taken in 5xFAD mice at 18 months.](https://figures.cochat.ai/paper-figures/f83acf31b4484235aae9e12daa6ae285/galectin-3-a-rising-star-in-modulating-microglia-activation-under-conditions-of-figure-2.jpg)
![Fig. 3 Illustration from Yip et al. 2017 [14]: effect of the lack of galectin-3 on the neuronal survival in cortex and hippocampus after TBI. Representative pictures of NeuN in different regions (left panel). Representative image of toluidine blue staining in wild-type and galectin-3 knockout mice (right panel). Note neuroprotection at 24 h and limited injury size 21 days after the TBI in Gal-3 KO mice. Scale bars are 100 and 1000 µm respectively.](https://figures.cochat.ai/paper-figures/0252be45eaae4ed9b24e5f87ea3e1f71/galectin-3-a-rising-star-in-modulating-microglia-activation-under-conditions-of-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both AD patients and Aβ amyloidosis model mice, Gal-3 is significantly elevated in microglia clustered around Aβ plaques, where it induces neuroinflammation and neurodegeneration17,18.”
From Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models (2026) · cites this paper as [17]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
The Glial Nature of Embryonic and Adult Neural Stem Cells
Kriegstein, A., & Alvarez-Buylla, A. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135600 · Cited by 2,475 · cited 4×
“Supporting the beneficial role of Gal-3 in EAE, the absence of Gal-3 in a virus-induced demyelination model decreased the number of immune cells in the SVZ and restored proliferation [113].”
BackgroundInfluentialHammond, T. R., Dufort, C., Dissing-Olesen, L., Giera, S., Young, A., Wysoker, A., Walker, A. J., Segel, M., Nemesh, J., Saunders, A., et al. (2018) · doi:10.1101/406140 · Cited by 2,225
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
A polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Galectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
Research works printed but not linked: 1
- Burguillos MA, Svensson M, Schulte T, Boza-Serrano A, Garcia-Quintanilla A, Kavanagh E, et al. Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation. Cell Rep. 2015;10:1626–38. · DOI · Paper page
Cited by
Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases
Javanmehr, N., Saleki, K., Alijanizadeh, P., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02637-1 · Cited by 118
Melchiorri, D., Merlo, S., Micallef, B., Borg, J.-J., & Dráfi, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1196413 · Cited by 86
Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00589-x · Cited by 76
How microglia contribute to the induction and maintenance of neuropathic pain
Malcangio, M., & Sideris-Lampretsas, G. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00914-5 · Cited by 71
Macrophages protect against sensory axon loss in peripheral neuropathy
Hakim, S., Jain, A., Adamson, S. S., Petrova, V., Indajang, J., Kim, H. W., Kawaguchi, R., Wang, Q., Duran, E. S., Nelson, D., et al. (2025) · Nature · doi:10.1038/s41586-024-08535-1 · Cited by 68
Metadata
- Authors
- García-Revilla, J., Boza-Serrano, A., Espinosa-Oliva, A. M., Soto, M. S., Deierborg, T., Ruiz, R., de Pablos, R. M., Burguillos, M. A., & Venero, J. L.
- Affiliations
- Instituto de Biomedicina de Sevilla (ES)
- Lund University (SE)
- Corresponding author
- Venero, Jose L.
- ORCID
- Venue
- Cell Death & Disease
- Published
- 2022-07-20
- Volume
- 13
- Issue
- 7
- Pages
- 628-628
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC9300700
- OpenAlex
- W4286253573
- Cited by
- 156
- References
- 151
- Citations by year
- 2026: 28 · 2025: 57 · 2024: 54 · 2023: 13 · 2022: 4
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Deposito de Investigacion Universidad de Sevilla (University of Seville) (submittedVersion, cc-by-nc-nd)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Universidad de Sevilla (US-1264806)
- Ministerio de Ciencia, Innovación y Universidades (RTI2018-098645-B-100, PID2019, PID2021-124096OB-I00, RYC-2017, FEDER/UE RTI2018-098645-B-100, RTI2018)
- Lunds Universitet
- Vetenskapsrådet (2019-06333)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- galectin-3, microglial activation, neurodegeneration, disease-associated microglia, pattern recognition receptors, TLR4, TREM2, lectins, neuroprotection, neurotoxicity, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, traumatic brain injury, stroke
- MeSH terms
- Alzheimer Disease, Humans, Parkinson Disease, Microglia, Galectin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration. https://app.cochat.ai/papers/10.1038/s41419-022-05058-3
- The paper
- García-Revilla, J., Boza-Serrano, A., Espinosa-Oliva, A. M., Soto, M. S., Deierborg, T., Ruiz, R., de Pablos, R. M., Burguillos, M. A., & Venero, J. L. (2022). Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration. Cell Death & Disease. https://doi.org/10.1038/s41419-022-05058-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.